Isoliquiritigenin alleviates abnormal sarcomere contraction and inflammation in myofascial trigger points via the IL-17RA/Act1/p38 pathway in rats
{{output}}
Background: Myofascial trigger points (MTrPs) are a primary cause of myofascial pain syndrome. Current studies suggest that MTrPs consist of persistent sarcomere contraction and an inflammatory microenvironment. IL-17 has been im... ...
